​
​

RAPT Therapeutics (RAPT) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

RAPT Therapeutics Revenue Highlights

00

RAPT Therapeutics Revenue by Period

RAPT Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$1.53M-59.95%
2021-12-31$3.81M-24.38%
2020-12-31$5.04M100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31--

RAPT Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

RAPT Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$5.29M100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$641.00K100.00%
2022-09-30--100.00%
2022-06-30$886.00K38.22%
2022-03-31$641.00K-15.21%
2021-12-31$756.00K-21.74%
2021-09-30$966.00K11.16%
2021-06-30$869.00K-28.89%
2021-03-31$1.22M-6.14%
2020-12-31$1.30M-14.79%
2020-09-30$1.53M19.66%
2020-06-30$1.28M36.58%
2020-03-31$935.00K100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

RAPT Therapeutics generated - in revenue during Q2 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

RAPT Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ARVNArvinas$78.50M$102.40M
RLAYRelay Therapeutics$25.55M-
HOWLWerewolf Therapeutics$19.94M$1.14M
IKNAIkena Oncology$9.16M-
STOKStoke Therapeutics$8.78M$4.89M
MOLNMolecular Partners$7.04M$2.74M
HCWBHCW Biologics$2.84M$426.42K
PLRXPliant Therapeutics$1.58M-
ANEBAnebulo Pharmaceuticals--
DSGNDesign Therapeutics--
RAPTRAPT Therapeutics--
BDTXBlack Diamond Therapeutics--
ANTXAN2 Therapeutics--
PHVSPharvaris--
CNTBConnect Biopharma--
ELYMEliem Therapeutics--
PMVPPMV Pharmaceuticals--
MLYSMineralys Therapeutics--
GLUEMonte Rosa Therapeutics-$4.70M
PEPGPepGen--
TYRATyra Biosciences--
XLOXilio Therapeutics-$2.36M

RAPT Revenue FAQ

What is RAPT Therapeutics’s yearly revenue?

RAPT Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $1.53M, representing a decrease of -59.95% compared to 2021. RAPT's yearly revenue for 2021 was $3.81M, representing a decrease of -24.38% compared to 2020.

What is RAPT Therapeutics’s quarterly revenue?

RAPT Therapeutics's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). RAPT's quarterly revenue for Q4 2023 was $5.29M, a 100.00% increase from the previous quarter (Q3 2023), and a 724.96% increase year-over-year (Q4 2022).

What is RAPT Therapeutics’s revenue growth rate?

RAPT Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.